Observational studyBMC cancer2025

Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a multi-center retrospective study.

Weibin Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.